კოქრეინის კლინიკური პასუხები
- In people with chronic obstructive pulmonary disease, what are the effects of integrated disease management interventions?
- What are the benefits and harms of antibiotics in people attending the intensive care unit or admitted to hospital with exacerbations of chronic obstructive pulmonary disease?
- How does longer corticosteroid treatment (>7 days) compare with shorter (≤7 days) in people with exacerbations of chronic obstructive pulmonary disease?
- How does umeclidinium bromide compare with placebo for people with chronic obstructive pulmonary disease (COPD)?
- How does long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) compare with LABA plus inhaled corticosteroid (ICS) for people with stable chronic obstructive pulmonary disease (COPD)?
- What are the longer-term (>6 months) effects of inhaled corticosteroids in people with stable chronic obstructive pulmonary disease?
- In people with chronic obstructive pulmonary disease (COPD), what are the effects of combined corticosteroid and long-acting beta-agonist (LABA) in one inhaler versus LABA alone?
- What are the effects of influenza vaccine in people with chronic obstructive pulmonary disease (COPD)?
- In people with chronic bronchitis or chronic obstructive pulmonary disease, how do mucolytic agents compare with placebo?
- What are the effects of pulmonary rehabilitation after exacerbation in people with chronic obstructive pulmonary disease?
- How does bronchoscopic lung volume reduction compare with medical therapy in people with chronic obstructive pulmonary disease?
- What is the impact of airway clearance techniques when treating acute exacerbations of COPD?
- What are the effects of airway clearance techniques in people with stable COPD?
- How does lung volume reduction surgery compare with usual medical care in people with diffuse emphysema?
ამ მასალის გამოყენება ექვემდებარება ჩვენს წესებს